Score Breakdown
Offering Ability
40
Cash Runway
85
Float Risk
40
Warrant Exposure
40
Convertible Debt
15
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 33%
🔄 Reverse Split
model est. 45%
• 50-day avg $1.41 approaching $1 threshold
• Only 5 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 5 months remaining
Market Data
Market Cap$47.26M
Shares Outstanding32.37M
Float18.41M
Cash$89.6K
Debt$12.5K
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest43
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-09-30
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual VICP Dilution Snapshot
Vicapsys Life Sciences, Inc. (VICP) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for VICP: xbrl on 2024-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: